Iambic celebrates its IPO at Nasdaq MarketSite @nasdaq
Iambic celebrates its IPO at Nasdaq MarketSite  @nasdaq
Uploaded October 2026 | Updated November 2026, 3 hours ago
Iambic is pursuing a fundamental shift in the biopharmaceutical industry through molecular superintelligence. Now, that vision comes to the public markets under the ticker $IAM. #NasdaqListed
Iambic celebrates its IPO at Nasdaq MarketSiteThe Signal: Lektra1:1 with Nasdaq: General Fusion CEO Greg Twinney1:1 with Nasdaq: Lime CEO Wayne TingElectra Therapeutics celebrates its Nasdaq listingA behind the scenes look at SpaceXs IPO day at NasdaqNasdaq Chair & CEO Adena Friedman: Building a National Strategy Against Financial CrimeSB Champs Jason and Devin McCourty, discuss the importance of PAC, financial literacy and moreAPA Corporation is Built in TexasKimi Antonelli on being smuggled into the pit lane at age 8SpaceX CFO Bret Johnsen on his winning formula for successSpaceX Starship Flight 15 lights up the Nasdaq Tower
Nasdaq |

Iambic celebrates its IPO at Nasdaq MarketSite

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER